MICHAEL FRUMOVITZ to B7-H1 Antigen
This is a "connection" page, showing publications MICHAEL FRUMOVITZ has written about B7-H1 Antigen.
Connection Strength
0.048
-
Phase II evaluation of nivolumab in the treatment of persistent or recurrent cervical cancer (NCT02257528/NRG-GY002). Gynecol Oncol. 2020 04; 157(1):161-166.
Score: 0.026
-
Potential immunotherapy targets in recurrent cervical cancer. Gynecol Oncol. 2017 06; 145(3):462-468.
Score: 0.021